Science
Mechanism of Action
Ononis Arvensis Root Extract operates through several distinct mechanisms to benefit the skin. Its potent antioxidant capabilities stem from a high concentration of phenolic acids and flavonoid glycosides, which effectively scavenge free radicals and mitigate UV-induced photoaging. The extract demonstrates anti-inflammatory action by inhibiting the release of pro-inflammatory cytokines, specifically IL-8 and TNF-α, from LPS-stimulated human neutrophils, potentially by antagonizing Toll-like Receptor 4 (TLR4) or interfering with its signaling pathways. Furthermore, it possesses antibacterial and antifungal properties, including significant anti-biofilm potential. Traditionally, it has been utilized to soothe various skin conditions such as itches, wounds, burns, and eczema. The extract also shows promise as a skin brightening agent through its reported inhibition of tyrosinase, a key enzyme in melanin synthesis, and provides general skin conditioning benefits.
Research
Clinical Evidence
Low confidenceN/A
Key findings
- 01 Studies on a related species, *Ononis spinosa*, demonstrated anti-inflammatory effects: a dichloromethane root extract (OS1) inhibited IL-8 and TNF-α release from LPS-stimulated human neutrophils in a concentration-dependent manner, with effective ranges between 25-100 µg/ml. Significant inhibition was also observed from isolated compounds like α-onocerin.
- 02 Ethyl acetate and methanolic root extracts of *O. spinosa* were found to reduce inflammation by 40.4% and 35.4%, respectively, in experimental models.
- 03 Crude extracts of *Ononis mitissima* exhibited medium anti-inflammatory activity at 500 µg/ml, showing inhibition percentages between 11% and 33% (for ethyl acetate, n-butanol, and petroleum ether extracts respectively), though this was less potent than the reference compound diclofenac (86%).
- 04 A methanolic extract of *O. spinosa* demonstrated antifungal activity at 0.02 mg/mL against various microfungi, with Penicillium aurantiogriseum being particularly sensitive to its inhibitory effect.
- 05 It is important to note that the detailed clinical efficacy data provided above are derived from studies on related *Ononis* species (*Ononis spinosa* and *Ononis mitissima*), and specific clinical trials directly evaluating the efficacy of *Ononis Arvensis Root Extract* in humans for these claims are not presented in the available research.
Transparency
Dusting Analysis
The Formula
Formulation
Safety
Safety Profile
The Cosmetic Ingredient Review (CIR) Expert Panel classified 'Ononis Arvensis Root Extract' under 'Zero use ingredients with Insufficient Data' as of September 2010, indicating a lack of sufficient toxicological and exposure data to fully assess its safety for cosmetic applications. No specific SCCS or FDA status was identified. However, INCIDecoder suggests a low irritancy potential for this ingredient.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Ononis Arvensis Root Extract demonstrates a compelling array of potential benefits for skin, including antioxidant, anti-inflammatory, antimicrobial, and brightening effects; however, its classification by CIR as having 'insufficient data' for safety, coupled with clinical studies primarily on related species, mandates further direct research for confident and precise integration into advanced skincare formulations.
Related
Similar Ingredients
Finding similar ingredients…